These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 36189346)

  • 21. Re-evaluation of routine dengue virus serology in travelers in the era of Zika virus emergence.
    van Meer MPA; Mögling R; Klaasse J; Chandler FD; Pas SD; van der Eijk AA; Koopmans MPG; Reusken CBEM; GeurtsvanKessel CH
    J Clin Virol; 2017 Jul; 92():25-31. PubMed ID: 28505571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibody-based assay discriminates Zika virus infection from other flaviviruses.
    Balmaseda A; Stettler K; Medialdea-Carrera R; Collado D; Jin X; Zambrana JV; Jaconi S; Cameroni E; Saborio S; Rovida F; Percivalle E; Ijaz S; Dicks S; Ushiro-Lumb I; Barzon L; Siqueira P; Brown DWG; Baldanti F; Tedder R; Zambon M; de Filippis AMB; Harris E; Corti D
    Proc Natl Acad Sci U S A; 2017 Aug; 114(31):8384-8389. PubMed ID: 28716913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinguishing West Nile virus infection using a recombinant envelope protein with mutations in the conserved fusion-loop.
    Chabierski S; Barzon L; Papa A; Niedrig M; Bramson JL; Richner JM; Palù G; Diamond MS; Ulbert S
    BMC Infect Dis; 2014 May; 14():246. PubMed ID: 24884467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity.
    Lai H; Paul AM; Sun H; He J; Yang M; Bai F; Chen Q
    Vaccine; 2018 Mar; 36(14):1846-1852. PubMed ID: 29490880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Compensating for cross-reactions using avidity and computation in a suspension multiplex immunoassay for serotyping of Zika versus other flavivirus infections.
    Rönnberg B; Gustafsson Å; Vapalahti O; Emmerich P; Lundkvist Å; Schmidt-Chanasit J; Blomberg J
    Med Microbiol Immunol; 2017 Oct; 206(5):383-401. PubMed ID: 28852878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequency of Zika Virus Immunoglobulin M Antibody in Persons with West Nile Virus Infection.
    Hills SL; Laven J; Biggerstaff BJ; Kosoy O; Staples JE; Panella A
    Vector Borne Zoonotic Dis; 2021 Oct; 21(10):817-821. PubMed ID: 34292777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute West Nile virus neuroinvasive infections: cross-reactivity with dengue virus and tick-borne encephalitis virus.
    Papa A; Karabaxoglou D; Kansouzidou A
    J Med Virol; 2011 Oct; 83(10):1861-5. PubMed ID: 21837806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Flavivirus-induced antibody cross-reactivity.
    Mansfield KL; Horton DL; Johnson N; Li L; Barrett ADT; Smith DJ; Galbraith SE; Solomon T; Fooks AR
    J Gen Virol; 2011 Dec; 92(Pt 12):2821-2829. PubMed ID: 21900425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cross-Reactive T Cell Immunity to Dengue and Zika Viruses: New Insights Into Vaccine Development.
    Elong Ngono A; Shresta S
    Front Immunol; 2019; 10():1316. PubMed ID: 31244855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flavivirus proteases: The viral Achilles heel to prevent future pandemics.
    Teramoto T; Choi KH; Padmanabhan R
    Antiviral Res; 2023 Feb; 210():105516. PubMed ID: 36586467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Added value of IgA antibodies against Zika virus non-structural protein 1 in the diagnosis of acute Zika virus infections.
    Warnecke JM; Lattwein E; Saschenbrecker S; Stöcker W; Schlumberger W; Steinhagen K
    J Virol Methods; 2019 May; 267():8-15. PubMed ID: 30779938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunoglobulin M seroneutralization for improved confirmation of Japanese encephalitis virus infection in a flavivirus-endemic area.
    Bharucha T; Ayhan N; Pastorino B; Rattanavong S; Vongsouvath M; Mayxay M; Changthongthip A; Sengvilaipaseuth O; Phonemixay O; Pommier JD; Gorman C; Zitzmann N; Newton PN; de Lamballerie X; Dubot-Pérès A
    Trans R Soc Trop Med Hyg; 2022 Nov; 116(11):1032-1042. PubMed ID: 35593182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of Serologic Cross-Reactivity Between Dengue Virus and SARS-CoV-2 in Patients with Acute Febrile Illness - United States and Puerto Rico, April 2020-March 2021.
    Munoz-Jordan J; Cardona J; Beltrán M; Colón C; Schiffer J; Stewart-Clark E; Zellner B; Semenova V; Li Y; Jia LT; Maniatis P; Pawloski L; Adams L; Paz-Bailey G; Rivera-Amill V; Medina F
    MMWR Morb Mortal Wkly Rep; 2022 Mar; 71(10):375-377. PubMed ID: 35271558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dengue and zika seropositivity, burden, endemicity, and cocirculation antibodies in Nigeria.
    Asaga Mac P; Tadele M; Airiohuodion PE; Nisansala T; Zubair S; Aigohbahi J; Anyaike C; Velayudha R; Kroeger A; Panning M
    Ann Med; 2023 Dec; 55(1):652-662. PubMed ID: 37074313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Engineered flavivirus vaccines control induction of crossreactive infection-enhancing and -neutralizing antibodies.
    Yamanaka A; Rattanaamnuaychai P; Matsuda M; Suzuki R; Matsuura Y; Tatsumi M; Konishi E
    Vaccine; 2022 Oct; 40(42):6004-6011. PubMed ID: 36109279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serodiagnosis of Zika virus (ZIKV) infections by a novel NS1-based ELISA devoid of cross-reactivity with dengue virus antibodies: a multicohort study of assay performance, 2015 to 2016.
    Steinhagen K; Probst C; Radzimski C; Schmidt-Chanasit J; Emmerich P; van Esbroeck M; Schinkel J; Grobusch MP; Goorhuis A; Warnecke JM; Lattwein E; Komorowski L; Deerberg A; Saschenbrecker S; Stöcker W; Schlumberger W
    Euro Surveill; 2016 Dec; 21(50):. PubMed ID: 28006649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of commercial serological assays in Malaysia for detection of anti-Zika virus antibodies.
    Khoo HY; Lee HY; Khor CS; Tan KK; AbuBakar S
    Trop Biomed; 2021 Dec; 38(4):613-621. PubMed ID: 35001928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Flavivirus cross-reactivity in serological tests and Guillain-Barré syndrome in a hematopoietic stem cell transplant patient: A case report.
    Raboni SM; Bonfim C; Almeida BM; Zanluca C; Koishi AC; Rodrigues PRVP; Kay CK; Ribeiro LL; Scola RH; Duarte Dos Santos CN
    Transpl Infect Dis; 2017 Aug; 19(4):. PubMed ID: 28306183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antigenic comparison of envelope protein E between Japanese encephalitis virus and some other flaviviruses using monoclonal antibodies.
    Kimura-Kuroda J; Yasui K
    J Gen Virol; 1986 Dec; 67 ( Pt 12)():2663-72. PubMed ID: 2432163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Specificity of the Persistent IgM Neutralizing Antibody Response in Zika Virus Infections among Individuals with Prior Dengue Virus Exposure.
    Calvert AE; Horiuchi K; Boroughs KL; Ong YT; Anderson KM; Biggerstaff BJ; Stone M; Simmons G; Busch MP; Huang CY
    J Clin Microbiol; 2021 Jul; 59(8):e0040021. PubMed ID: 33980647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.